APA (7th ed.) Citation

Lima, M., Dutra, S., Gomes, F. V., Bilhim, T., & Coimbra, É. (2018). Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment.

Chicago Style (17th ed.) Citation

Lima, Mariana, Sofia Dutra, Filipe Veloso Gomes, Tiago Bilhim, and Élia Coimbra. Risk Factors for the Development of Postembolization Syndrome After Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment. 2018.

MLA (8th ed.) Citation

Lima, Mariana, et al. Risk Factors for the Development of Postembolization Syndrome After Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment. 2018.